pembrolizumab
merck
['thank you', 'kn189', 'kn407']
no plateau and no reason to be satisfied, we must continue research. thank you for discussing kn189 and kn407 #esmo22 
Medical Oncologist @KantonsspitalLU | Associate Professor @unibern | member @sakk_ch @etop_eu @myESMO @IASLC